Endogenous Damage-Associated Molecular Pattern Molecules at the Crossroads of Inflammation and Cancer

被引:228
作者
Srikrishna, Geetha [1 ]
Freeze, Hudson H. [1 ]
机构
[1] Burnham Inst Med Res, Tumor Microenvironm Program, Ctr Canc, La Jolla, CA 92037 USA
来源
NEOPLASIA | 2009年 / 11卷 / 07期
基金
美国国家卫生研究院;
关键词
GLYCATION END-PRODUCTS; MOBILITY GROUP BOX-1; NF-KAPPA-B; CALCIUM-BINDING PROTEINS; T-CELL-ACTIVATION; TOLL-LIKE RECEPTORS; ACUTE LUNG INJURY; S100; PROTEINS; RECOGNITION RECEPTORS; CARBOXYLATED GLYCANS;
D O I
10.1593/neo.09284
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inflammatory mediators play important roles in the development and progression of cancer. Cellular stress, damage, inflammation, and necrotic cell death cause release of endogenous damage-associated molecular pattern ( DAMP) molecules or alarmins, which alert the host of danger by triggering immune responses and activating repair mechanisms through their interaction with pattern recognition receptors. Recent studies show that abnormal persistence of these molecules in chronic inflammation and in tumor microenvironments underlies carcinogenesis and tumor progression, indicating that DAMP molecules and their receptors could provide novel targets for therapy. This review focuses on the role of DAMP molecules high-mobility group box 1 and S100 proteins in inflammation, tumor growth, and early metastatic events.
引用
收藏
页码:615 / 628
页数:14
相关论文
共 234 条
[1]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[2]   Pathways connecting inflammation and cancer [J].
Allavena, Paola ;
Garlanda, Cecilia ;
Borrello, Maria Grazia ;
Sica, Antonio ;
Mantovani, Alberto .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (01) :3-10
[3]   V domain of RAGE interacts with AGEs on prostate carcinoma cells [J].
Allmen, Edith Uetz-von ;
Koch, Michael ;
Fritz, Guenter ;
Legler, Daniel F. .
PROSTATE, 2008, 68 (07) :748-758
[4]   High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes [J].
Andersson, U ;
Wang, HC ;
Palmblad, K ;
Aveberger, AC ;
Bloom, O ;
Erlandsson-Harris, H ;
Janson, A ;
Kokkola, R ;
Zhang, MH ;
Yang, H ;
Tracey, KJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04) :565-570
[5]  
[Anonymous], NOVARTIS FDN S
[6]  
[Anonymous], NOVARTIS FDN S
[7]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[8]   S100P promotes pancreatic cancer growth, survival, and invasion [J].
Arumugam, T ;
Simeone, DM ;
Van Golen, K ;
Logsdon, CD .
CLINICAL CANCER RESEARCH, 2005, 11 (15) :5356-5364
[9]   Mechanisms for the prevention of gastrointestinal cancer:: The role of prostaglandin E2 [J].
Backlund, MG ;
Mann, JR ;
DuBois, RN .
ONCOLOGY, 2005, 69 :28-32
[10]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545